JanosLTanyiMD

PubMed

• 4 citations
  Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer.
  Stephanie L Wethington, Payal D Shah, Lainie Martin, Janos L Tanyi, Nawar Latif, Mark Morgan, Drew A Torigian, Diego Rodriguez, Simon A Smith, Emma Dean, Susan M Domch...> ;Clinical Cancer Research. 2023 Aug 1
• A retrospective case series of Mohs micrographic surgery and interdisciplinary management of female genital skin cancers: Local recurrence rates and patient-reported o...
  Shannon T Nugent, Leela K Raj, Nawar A Latif, Lori Cory, Janos L Tanyi, Stephen J Kovach 3rd, John P Fischer, Joshua Fosnot, Ines C Lin, Jeremy R Etzkorn, Thuzar M Shi...> ;Journal of the American Academy of Dermatology. 2023 Aug 1
• 6 citations
  [18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study.
  Austin R Pantel, Sarah B Gitto, Mehran Makvandi, Hyoung Kim, Sergey Medvedv, Joanna K Weeks, Drew A Torigian, Chia-Ju Hsieh, Benjamin Ferman, Nawar A Latif, Janos L Ta...> ;Clinical Cancer Research. 2023 Apr 14
• 3 citations
  Systematic pan-cancer characterization of nuclear receptors identifies potential cancer biomarkers and therapeutic targets.
  Junjie Jiang, Jiao Yuan, Zhongyi Hu, Mu Xu, Youyou Zhang, Meixiao Long, Yi Fan, Kathleen T. Montone, Janos L. Tanyi, Omid Tavana, Ho Man Chan, Lin Zhang, Xiaowen Hu> ;Cancer Research. 2021 Nov 8
• 54 citations
  Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation.
  Jaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan, David Barras, Isaac Crespo, Alizée J. Grimm, Julia Casado, Raphael Genolet, Fabrizio Benedetti, Alexandre Wicky...> ;Cancer Cell. 2021 Nov 2
• 50 citations
  Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer.
  Payal D. Shah, Stephanie L. Wethington, Cheyenne Pagan, Nawar A. Latif, Janos L. Tanyi, Lainie P. Martin, Mark A. Morgan, Robert A. Burger, Ashley Haggerty, Haley Zarr...> ;Gynecologic Oncology. 2021 Oct 4
• 1 citations
  Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
  Janos L. Tanyi, Cheryl Lai-Lai Chiang, Johanna Chiffelle, Anne-Christine Thierry, Petra Baumgartener, Florian Huber, Christine Goepfert, David Tarussio, Stephanie Tiss...> ;NPJ Vaccines. 2021 May 4
• 18 citations
  Intraoperative molecular imaging clinical trials: a review of 2020 conference proceedings.
  Feredun Azari, Gregory T. Kennedy, Elizabeth Bernstein, Constantinos G. Hadjipanayis, Alexander L. Vahrmeijer, Barbara L. Smith, Eben L. Rosenthal, Baran D. Sumer, Jie...> ;Journal of Biomedical Optics. 2021 May 1
• 27 citations
  Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
  Janos L. Tanyi, Cheryl Lai-Lai Chiang, Johanna Chiffelle, Anne-Christine Thierry, Petra Baumgartener, Florian Huber, Christine Goepfert, David Tarussio, Stephanie Tiss...> ;NPJ Vaccines. 2021 Mar 15
• 86 citations
  Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I.
  Kathleen N. Moore, Amit M. Oza, Nicoletta Colombo, Ana Oaknin, Giovanni Scambia, Domenica Lorusso, Gottfried E. Konecny, Susana Banerjee, Conleth G. Murphy, Janos L. T...> ;Annals of Oncology. 2021 Jun 1
• Join now to see all